Endonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENDV | AMGN | GILD | CELG | ILMN |
| Company | Endonovo Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0028 | 264.63 | 66.25 | 108.01 | 117.69 |
| High | 0.0029 | 264.63 | 66.48 | 108.59 | 118.82 |
| Low | 0.0028 | 260.68 | 66.16 | 107.27 | 117.66 |
| Last | 0.0028 | 263.64 | 66.45 | 108.24 | 118.00 |
| Change | +0.0004 | +0.89 | +0.29 | +0.11 | +1.31 |
| % Change | +16.67% | +0.34% | +0.44% | +0.10% | +1.12% |
| Volume | 74,100 | 328,506 | 615,073 | 191,230,496 | 73,935 |
| 20-Day Average Volume | 3,091,835 | 2,091,507 | 5,947,314 | 16,188,930 | 1,431,344 |
| Previous Close | 0.0024 | 262.75 | 66.16 | 108.13 | 116.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0028 | 272.29 | 69.87 | 108.17 | 128.43 |
| 20-Day Raw Stochastic | 21.05% | 9.81% | 4.89% | 63.25% | 10.93% |
| 20-Day Relative Strength | 46.47% | 37.60% | 28.67% | 64.69% | 37.71% |
| Weighted Alpha | -80.15 | +4.66 | -25.06 | +46.30 | -44.87 |
| Today's Opinion | 96% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 72% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.67% since 04/09/24 | -1.42% since 04/12/24 | -2.61% since 04/12/24 | -1.97% since 11/13/19 | -6.83% since 04/12/24 |
| Low | 0.0024 on 04/17/24 | 260.75 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 115.73 on 04/18/24 |
| High | 0.0036 on 04/10/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 128.28 on 04/15/24 |
| 1-Month | |||||
| %Chg | +21.74% since 03/18/24 | -3.04% since 03/19/24 | -9.70% since 03/19/24 | +5.14% since 10/18/19 | -11.09% since 03/19/24 |
| Low | 0.0020 on 03/27/24 | 260.75 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 0.0058 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | -70.53% since 01/17/24 | -14.40% since 01/19/24 | -24.06% since 01/19/24 | +13.63% since 08/20/19 | -12.87% since 01/19/24 |
| Low | 0.0010 on 02/07/24 | 260.75 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 0.0093 on 01/23/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -78.46% since 10/18/23 | -6.10% since 10/19/23 | -15.49% since 10/19/23 | +14.14% since 05/20/19 | -1.33% since 10/19/23 |
| Low | 0.0010 on 02/07/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 0.0160 on 12/04/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 933 | 140,812,720 | 82,374,304 | 77,035,920 | 18,583,468 |
| Shares Outstanding, K | 333,038 | 535,919 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 140,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -18,470,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 50,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | 2,060,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | -1.41 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 12/28/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/27/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 135.97 |